Insulin infusion to treat severe hypertriglyceridemia associated with pegaspargase therapy: A case report

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 2, 2011, Pages

  Lawson, Eileen B ^a   Gottschalk, Michael ^b,c   Schiff, Deborah E ^b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

acute lymphoblastic leukemia (ALL); Apo E polymorphism; hypertriglyceridemia; insulin; pegaspargase

Indexed keywords

AMYLASE; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ASPARAGINASE MACROGOL; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VINCRISTINE;

ABDOMINAL PAIN; ACUTE LEUKEMIA; AMYLASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHILD; CHOLESTEROL BLOOD LEVEL; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESCHERICHIA COLI; FAMILY HISTORY; FOLLOW UP; GENETIC PREDISPOSITION; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIA; INSULIN INFUSION; IRRITABILITY; LOW FAT DIET; MALE; NAUSEA; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; TACHYCARDIA; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; TRICHOSPORON; VOMITING;

6-MERCAPTOPURINE; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CYCLOPHOSPHAMIDE; CYTARABINE; HUMANS; HYPERTRIGLYCERIDEMIA; INFUSIONS, INTRAVENOUS; INSULIN; LEUKEMIA; MALE; POLYETHYLENE GLYCOLS;

EID: 79952190056     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181f46c22     Document Type: Article

References (31)

1. Dinndorf PA, Gootenberg J, Cohen MH, et al. FDA drug approval summary: Pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). Oncologist. 2007;12:991-998. (Pubitemid 47359142)
2. Bolaman Z, Yavasoglu I, Kadikoylu G. Plasmapheresis in asparaginase-induced pancreatitis. Transfusion. 2009;49:185. [author reply 185-186].
3. Cremer P, Lakomek M, Beck W, et al. The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia. Eur J Pediatr. 1988;147:64-67. (Pubitemid 18027564)
4. Hoogerbrugge N, Jansen H, Hoogerbrugge PM. Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity. Leukemia. 1997;11:1377-1379. (Pubitemid 27387319)
5. Jain S, Naithani R, Kapoor G, et al. L-asparaginase induced severe hypertriglyceridemia in acute lymphoblastic leukemia with 11q23 abnormality. Leuk Res. 2009;33:e194.
6. Keung YK, Rizk R, Wu XY, et al. Drug-induced hypertriglyceridemia with and without pancreatitis. South Med J. 1999; 92:912-914. (Pubitemid 29446348)
7. Kfoury-Baz EM, Nassar RA, Tanios RF, et al. Plasmapheresis in asparaginase-induced hypertriglyceridemia. Transfusion. 2008;48:1227-1230. (Pubitemid 351793486)
8. Konya H, Tamura S, Miyazaki E, et al. L-asparaginaseinduced hyperlipidemia in a case of acute lymphoblastic leukemia. Rinsho Ketsueki. 1991;32:250-254.
9. Nakagawa M, Kimura S, Fujimoto K, et al. A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis. Ther Apher Dial. 2008;12:509-513.
10. Parsons SK, Skapek SX, Neufeld EJ, et al. Asparaginaseassociated lipid abnormalities in children with acute lymphoblastic leukemia. Blood. 1997;89:1886-1895. (Pubitemid 27132102)
11. Ridola V, Buonuomo PS, Maurizi P, et al. Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis. Pediatr Blood Cancer. 2008;50:378-380.
12. Steinherz PG. Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. Cancer. 1994;74:3234-3239. (Pubitemid 24375082)
13. Tozuka M, Yamauchi K, Hidaka H, et al. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma. Ann Clin Lab Sci. 1997;27:351-357. (Pubitemid 27386469)
14. Cohen H, Bielorai B, Harats D, et al. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;54:703-706.
15. Yavasoglu I, Kadikoylu G, Bolaman Z. Treating hypertriglyceridemia. CMAJ. 2007;177:603-604. [author reply 604-605].
16. American Academy of Pediatrics. Normal Laboratory Values for Children. Available at: Http://www.pediatriccareonline.org/ pco/ub/view/Pediatric-Drug- Lookup/153930/0/Normal-Labora tory-Values-for-Children. Accessed on: November 25, 2009.
17. National Heart Lung and Blood Institute. Blood pressure tables for children and adolescents. National Heart Lung and Blood Institute; 2004;4. Available at: Http://www.nhlbi.nih. gov/guidelines/hypertension/child-tbl.htm. Accessed on: November 25,2009.
18. Hay WW, Hayward AR, Levin Mj, et al. Current Pediatric Diagnosis and Treatment. 15th ed. New York: Lange Medical Books/McGraw Hill; 2000:1345t.
19. Oettgen HF, Stephenson PA, Schwartz MK, et al. Toxicity of E. coli L-asparaginase in man. Cancer. 1970;25:253-278.
20. Brindley DN. Regulation of hepatic triacylglycerol synthesis and lipoprotein metabolism by glucocorticoids. Clin Sci (Lond). 1981;61:129-133. (Pubitemid 11010801)
21. Fried SK, Russell CD, Grauso NL, et al. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest. 1993;92:2191-2198. (Pubitemid 23333523)
22. Dinndorf PA, Gootenberg J, Cohen MH, et al. FDA drug approval summary: Pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). Oncologist. 2007;12:991-998. (Pubitemid 47359142)
23. Balakrishnan S, Colling C, Burkman T, et al. Apolipoprotein E gene polymorphism alters lipids before pancreas transplantation. Transplantation. 2002;74:974-977. (Pubitemid 35191246)
24. Bayes B, Pastor MC, Lauzurica R, et al. Apolipoprotein E alleles, dyslipemia and kidney transplantation. Transplant Proc. 2002;34:373. (Pubitemid 34311717)
25. Corbo RM, Scacchi R, Vilardo T, et al. Polymorphisms in the apolipoprotein E gene regulatory region in relation to coronary heart disease and their effect on plasma apolipoprotein E. Clin Chem Lab Med. 2001;39:2-6. (Pubitemid 32186270)
26. Kahraman S, Kiykim AA, Altun B, et al. Apolipoprotein E gene polymorphism in renal transplant recipients: Effects on lipid metabolism, atherosclerosis and allograft function. Clin Transplant. 2004;18:288-294. (Pubitemid 38744853)
27. Gorshkova IN, Kypreos KE, Gantz DL, et al. Biophysical properties of apolipoprotein E4 variants: Implications in molecular mechanisms of correction of hypertriglyceridemia. Biochemistry. 2008;47:12644-12654.
28. Fortson MR, Freedman SN, Webster PD III. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995;90:2134-2139.
29. Tsuang W, Navaneethan U, Ruiz L, et al. Hypertriglyceridemic pancreatitis: Presentation and management. Am J Gastroenterol. 2009;104:984-991.
30. Jain D, Zimmerschied J. Heparin and insulin for hypertriglyceridemia- induced pancreatitis: Case report. ScientificWorld- Journal. 2009;9:1230-1232.
31. Monga A, Arora A, Makkar RP, et al. Hypertriglyceridemiainduced acute pancreatitis-treatment with heparin and insulin. Indian J Gastroenterol. 2003;22:102-103. (Pubitemid 36775720)